Cover Image
市場調查報告書

逆流性食道炎 (胃食道逆流症) :全球臨床實驗趨勢

Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 336862
出版日期 內容資訊 英文 105 Pages
訂單完成後即時交付
價格
Back to Top
逆流性食道炎 (胃食道逆流症) :全球臨床實驗趨勢 Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015
出版日期: 2015年06月30日 內容資訊: 英文 105 Pages
簡介

本報告提供逆流性食道炎 (胃食道逆流症) 相關臨床研究的最新趨勢的相關分析、各地區的臨床實驗數量、臨床實驗的各階段進展、實驗對象採用狀況、有潛力的贊助商、各企業和研究機關的研究進展、有潛力的藥劑比較的資訊彙整。

簡介

  • 逆流性食道炎 (胃食道逆流症)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東、非洲主要國家的臨床實驗數量
    • 中南美主要5個國家的臨床實驗數量

G7各國的臨床實驗數量:腸胃疾病治療藥臨床實驗的逆流性食道炎 (胃食道逆流症) 的比例

G7各國的各階段臨床實驗數量

G7各國的臨床實驗數量:各進展狀況

E7各國的臨床實驗數量:腸胃疾病治療藥臨床實驗的逆流性食道炎 (胃食道逆流症) 的比例

E7各國的各階段臨床實驗數量

E7各國的臨床實驗數量:各進展狀況

各階段的臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況的臨床實驗數量

臨床實驗目標的達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商的各種類的臨床實驗數量

有潛力的贊助商

逆流性食道炎 (胃食道逆流症) 治療藥臨床實驗參與的主要企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • AstraZeneca Plc
    • 武田藥品工業
    • Eisai
    • Johnson & Johnson
    • Janssen Global Services, LLC
    • Indivior Plc
    • Pfizer Inc.
    • Novartis AG
    • Yuhan Corporation
    • Dr. Reddy's Laboratories Limited
  • 代表性研究機關、醫院臨床實驗概要
    • 島根大學
    • Mayo Clinic
    • Academic Medical Center
    • 順天堂大學醫學系
    • Seoul National University Hospital
    • 橫濱市立大學
    • General Public Hospital Zell am See
    • Guy's and St Thomas' NHS Foundation Trust
    • Hospital Authority
    • National Taiwan University Hospital

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2760CTIDB

GlobalData's clinical trial report, "Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015" provides an overview of Reflux Esophagitis (Gastroesophageal Reflux Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Reflux Esophagitis (Gastroesophageal Reflux Disease) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Reflux Esophagitis (Gastroesophageal Reflux Disease)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Reflux Esophagitis (Gastroesophageal Reflux Disease)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Janssen Global Services, LLC
      • Clinical Trial Overview of Janssen Global Services, LLC
      • Indivior Plc
      • Clinical Trial Overview of Indivior Plc
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Yuhan Corporation
      • Clinical Trial Overview of Yuhan Corporation
      • Dr. Reddy's Laboratories Limited
      • Clinical Trial Overview of Dr. Reddy's Laboratories Limited
    • Clinical Trial Overview of Top Institutes / Government
      • Shimane University
      • Clinical Trial Overview of Shimane University
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • Juntendo University School of Medicine
      • Clinical Trial Overview of Juntendo University School of Medicine
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Yokohama City University
      • Clinical Trial Overview of Yokohama City University
      • General Public Hospital Zell am See
      • Clinical Trial Overview of General Public Hospital Zell am See
      • Guy's and St Thomas' NHS Foundation Trust
      • Clinical Trial Overview of Guy's and St Thomas' NHS Foundation Trust
      • Hospital Authority
      • Clinical Trial Overview of Hospital Authority
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Region, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Indivior Plc, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yuhan Corporation, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shimane University, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by General Public Hospital Zell am See, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Guy's and St Thomas' NHS Foundation Trust, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015*

List of Figures

  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top